Post-diagnosis serum 25-hydroxyvitamin D concentrations in women treated for breast cancer participating in a lifestyle trial in Italy

• Main Authors: A. Fassio (Author), G. Porciello (Author), G. Carioli (Author), E. Palumbo (Author), S. Vitale (Author), A. Luongo (Author), C. Montagnese (Author), M. Prete (Author), M. Grimaldi (Author), R. Pica (Author), E. Rotondo (Author), L. Falzone (Author), I. Calabrese (Author), A. Minopoli (Author), B. Grilli (Author), M. Cuomo (Author), P.C. Fiorillo (Author), C. Evangelista (Author), E. Cavalcanti (Author), M. De Laurentiis (Author), D. Cianniello (Author), C. Pacilio (Author), M. Pinto (Author), G. Thomas (Author), M. Rinaldo (Author), M. D'Aiuto (Author), D. Serraino (Author), S. Massarut (Author), A. Steffan (Author), F. Ferraù (Author), R. Rossello (Author), F. Messina (Author), F. Catalano (Author), G. Adami (Author), F. Bertoldo (Author), M. Libra (Author), A. Crispo (Author), E. Celentano (Author), C. La Vecchia (Author), L.S.A. Augustin (Author), D. Gatti (Author)
• Format: Book
• Published: PAGEPress Publications, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective. To report cross-sectionally serum levels of 25-hydroxyvitamin D [25(OH)D] in women living in Italy within 12 months from breast cancer (BC) diagnosis. Methods. Baseline data were obtained from 394 women diagnosed with primary BC, enrolled from 2016 to 2019 in a lifestyle trial conducted i...